Definium Therapeutics, Inc. (DFTX) vs Edgewise Therapeutics, Inc. (EWTX)
Definium Therapeutics, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Definium Therapeutics, Inc. is the larger, with a market value of $4.9B against $4.4B — 1.1× the size. Across the 9 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Definium Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | DFTX | EWTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.09%) | (38.03%) | (57.72%) |
| Return on assets | (51.35%) | (36.09%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack